Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SELUMETINIB for Brain neoplasm: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 6 adverse event reports in the FDA FAERS database where SELUMETINIB was used for Brain neoplasm.

Most Reported Side Effects for SELUMETINIB

Side Effect Reports % Deaths Hosp.
Blood creatine phosphokinase increased 105 9.0% 1 7
Rash 89 7.6% 0 13
Off label use 78 6.7% 4 6
Paronychia 73 6.2% 1 8
Dermatitis acneiform 61 5.2% 1 5
Diarrhoea 59 5.0% 1 13
Fatigue 54 4.6% 1 9
Acne 52 4.4% 0 5
Nausea 49 4.2% 0 15
Death 47 4.0% 47 0
Alopecia 45 3.8% 0 9
Vomiting 40 3.4% 1 11
Abdominal pain 35 3.0% 0 5
Headache 33 2.8% 1 9
Pruritus 31 2.7% 0 2

Other Indications for SELUMETINIB

Neurofibromatosis (499) Neurofibroma (192) Brain neoplasm malignant (37) Nervous system neoplasm benign (18) Glioma (17) Neoplasm malignant (15) Neoplasm (14) Non-small cell lung cancer (14) Optic glioma (8) Acute lymphocytic leukaemia (5)

Other Drugs Used for Brain neoplasm

TEMOZOLOMIDE (286) BEVACIZUMAB (166) PROCARBAZINE (142) ETOPOSIDE (121) CARBOPLATIN (103) VINCRISTINE (93) CYCLOPHOSPHAMIDE (72) CISPLATIN (67) TRAMETINIB DIMETHYL SULFOXIDE (55) BEVACIZUMAB-AWWB (50)

Related Pages

SELUMETINIB Full Profile All Brain neoplasm Drugs SELUMETINIB Demographics SELUMETINIB Timeline